WeVote
Log In

Bill

Bill

HB 2750

Relating to use of a pharmacy benefit manager in which a health benefit plan issuer has a financial interest.

89th Legislature (2025) Introduced by Cody Harris

Texas bill prohibits health insurers from using pharmacy benefit managers in which they hold financial interests, aiming to eliminate conflicts of interest that may drive up drug costs.

Left pending in committee
#insurance--health&accident(i0422) #pharmacybenefitmanagers(s0648)
0
WeVote Research Nonpartisan
Bill Summary · HB 2750

Legislative bill overview

HB 2750 addresses conflicts of interest in pharmacy benefit management by restricting health insurance plan issuers from using pharmacy benefit managers (PBMs) in which they have a financial interest. The bill appears designed to prevent insurers from steering patients to PBMs that benefit the insurer's bottom line rather than prioritizing patient access and affordability.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling drug formularies and negotiating prices. When insurers own or have financial stakes in PBMs, they may prioritize profits over patient choice and medication access. This bill addresses a structural conflict of interest that consumer advocates argue inflates drug costs and limits treatment options.

Potential points of contention

  • Industry opposition: PBM and insurance industry groups may argue such restrictions limit business integration and competitive strategies, potentially reducing efficiency
  • Definition ambiguity: The bill's scope regarding what constitutes a "financial interest" could be debated—does it cover partial ownership, profit-sharing agreements, or only majority stakes?
  • Implementation complexity: Determining compliance and enforcing separation between related entities may create administrative challenges and litigation risk

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.